Familial hypercholesterolemia screening may reduce coronary artery disease prevalence - Clinical Trials Arena

6/15/2022 12:00:00 AM2 years 10 months ago
by GlobalData Healthcare
by GlobalData Healthcare
High levels of low‐density lipoprotein cholesterol (LDL‐C), colloquially referred to as 'bad cholesterol,' can lead to coronary artery disease (CAD), heart attacks and death. While bad cholesterol may
High levels of lowdensity lipoprotein cholesterol (LDLC), colloquially referred to as ‘bad cholesterol,’ can lead to coronary artery disease (CAD), heart attacks and death. While bad cholesterol may … [+2981 chars]
full article...